Mangalam Drugs And Organics Ltd.
₹26.94
-1 (-3.8%)
MANGALAM Share Price
As on August 19, 2026
SectorHealthcare
IndustryPharmaceuticals & Biotechnology
Basic IndustryPharmaceuticals
Market Cap₹ 43 Cr
P/E Ratio6.34
Dividend YieldN/A
Trendline Performance
We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.
Unlock Stock of the Month
T&C*
Company Information
Market Insights
Open28.68
High28.69
NSE SymbolMANGALAM
Close26.94
Low26.14
BSE Symbol532637
Previous Years High/Low
1 Year High84.21
3 Year High144.99
5 Year High173
1 Year Low22.8
3 Year Low22.8
5 Year Low22.8
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 27.73 | Bearish |
| 10-DMA | 27.43 | Bearish |
| 20-DMA | 27.3 | Bearish |
| 50-DMA | 27.93 | Bearish |
| 100-DMA | 28.69 | Bearish |
| 200-DMA | 32.94 | Bearish |
Historical Performance
1 Year
-67.2%
3 Years
-74.4%
5 Years
-81.5%
10 Years
-83.6%
Shareholding Pattern
%
Values Analysis
Loading chart...
Profit & Loss
Below figures are in Rs. Crores
| Particulars | Mar-2025 | Mar-2024 |
|---|---|---|
| Net Sales | 3,182 | 3,686 |
| Total Expenditure | 2,824 | 3,512 |
| Other Income | 5 | 1 |
| Operating Profit | 363 | 175 |
| Interest | 149 | 139 |
| Depreciation | 166 | 147 |
| Profit Before Tax | 48 | -111 |
| Consolidated Net Profit | 67 | -91 |
| Adjusted EPS | 4 | -6 |
Compounded Sales Growth
10 Years:-2.9
5 Years:-2.9
3 Years:-2.9
TTM:-2.9
Compounded Profit Growth
10 Years:-23.8
5 Years:-23.8
3 Years:-23.8
TTM:-23.8
Stock Price CAGR
10 Years:-16.5
5 Years:-28.5
3 Years:-36.5
TTM:-66.6
Return on Equity
10 Years:N/A
5 Years:N/A
3 Years:N/A
last year:4.2
Quarterly Results
Below figures are in Rs. Crores
| Particulars | Sep-2024 | Dec-2024 | Mar-2025 | Jul-2025 | Sep-2025 |
|---|---|---|---|---|---|
| Sales | 1,70,754 | 1,35,936 | 1,28,552 | 1,22,189 | 1,05,161 |
| Expenses | 63,042 | 56,557 | 52,457 | 45,459 | 34,856 |
| Operating Profit | 1,07,712 | 79,379 | 76,096 | 76,730 | 70,304 |
| OPM % | 63% | 58% | 59% | 63% | 67% |
| Other Income | 33,912 | 31,759 | 27,333 | 24,879 | 18,947 |
| Interest | 77,780 | 58,584 | 59,248 | 62,137 | 53,713 |
| Depreciation | 2,345 | 1,681 | 1,385 | 1,277 | 1,221 |
| Profit Before Tax | 61,498 | 50,873 | 42,796 | 38,195 | 34,318 |
| Tax % | 25% | 25% | 26% | 29% | 35% |
| Net Profit | 46,149 | 38,151 | 31,857 | 27,296 | 22,446 |
| EPS in Rs | 83 | 69 | 58 | 50 | 42 |
Balance Sheet
Below figures are in Rs. Crores
| Particulars | Mar-2025 | Mar-2024 |
|---|---|---|
| Share Capital | 158 | 158 |
| Total Reserves | 1,332 | 1,200 |
| Long-Term Borrowings | --- | --- |
| Total Non-Current Liabilities | 258 | 338 |
| Other Current Liabilities | 265 | 223 |
| Short Term Borrowings | 719 | 746 |
| Total Liabilities | 3,664 | 3,337 |
| Capital Work in Progress | --- | --- |
| Long Term Loans & Advances | 20 | 23 |
| Currents Investments | --- | --- |
| Short Term Loans and Advances | 169 | 215 |
| Total Current Assets | 1,990 | 1,760 |
| Total Assets | 3,664 | 3,337 |
| Adjusted Book Value | 90 | 86 |
0%
Positive
(80 to 100)
Neutral
(60 to 79)
Negative
(0 to 59)
- The stock has a low PE of 6.34, which may indicate undervaluation or subdued growth expectations.
- Over the last three years, the stock delivered a weak 3-year price CAGR of -36.2%, indicating poor shareholder returns.
- The stock carries a low beta of 0.5, suggesting lower volatility than the broader market.
- In the last financial year, the company reported an EBITDA of ₹363 million, reflecting positive operating performance.
- In the previous financial year, the company generated revenue of ₹3182 million, suggesting a mid-sized operation.
Investment Calculator
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 333787.6
No. of Shares: 12390 (Approx)
Performance:-66.6%
-666212.4
NIFTY Performance: -3.9%
1 day Top Gainers
Top Performing Stocks from the same sector
Get Your Portfolio Reviewed
Latest News
Stay Updated with Our Market Newsletters
